In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Joao Morais
Speaker
Joao Morais

Leiria Hospital Centre, Leiria (Portugal)

Specialities : Acute Coronary Syndromes , Acute Heart Failure, Pharmacology and Pharmacotherapy

JOAO MORAIS,1954, cardiologist (1988), head of the Cardiology Division of Leiria Hospital Centre (Portugal) since 2001, and professor in Oporto Medical School A particular interest was developed with the field of acute coronary syndromes in special with the topic of reperfusion strategies. Thrombosis and antithrombotics as well as heart failure, are also interest fields Within the last 20 years he was deeply involved with the Portuguese Society of Cardiology ( President 2017-2019) and President of the National Congress (2007). JM is currently member of the Nominating Committee of ESC. He was member of the Committee for Practice Guidelines (2004-8), member of the Nucleus of the Working Group on Thrombosis for more than 10 years ( chair 2016-2018) More than 350 abstracts were presented; 135 manuscripts were published in peer review journals; more than 500 presentations by invitation JM was awarded by the mayor of Leiria by high health services provided to the local community

22 presentations from this speaker

Conclusion - Use of single-pill combinations in patients with dyslipidemia and concomitant diseases.

Congress : EuroPrevent 2019

  • Session : Use of single-pill combinations in patients with dyslipidemia and concomitant diseases.
  • Speaker : J Morais (Leiria,PT)
  • Sponsored by SERVIER

Discussion.

Congress : EuroPrevent 2019

  • Session : Use of single-pill combinations in patients with dyslipidemia and concomitant diseases.
  • Speaker : M Farnier (Dijon,FR), DE Grobbee (Utrecht,NL), J Morais (Leiria,PT), C Vlachopoulos (Athens,GR)
  • Sponsored by SERVIER

Welcome to Lisbon.

Congress : EuroPrevent 2019

  • Session : EuroPrevent 2019 Inaugural Session
  • Speaker : J Morais (Leiria,PT)

Drug treatment for stable CAD

Congress : ESC Congress 2018

  • Session : Stable coronary artery disease: review, update, and State of the Art in 2018
  • Speaker : J Morais (Leiria,PT)

Coagulation, new oral anticoagulation and new contra-anticoagulation.

Congress : EuroEcho-Imaging 2017

  • Session : Advances in the EP lab I. When the cardiac imager meets the electrophysiologist : focus on atrial fibrillation
  • Speaker : J A C Morais (Leiria,PT)

Disseminated intravascular coagulation following cardiac arrest

Congress : ESC Congress 2017

  • Session : Managing complications in acute cardiac care
  • Speaker : J A C Morais (Leiria,PT)

Mechanical heart valves, bioprostheses, TAVI.

Congress : EHRA 2017

  • Session : Antithrombotic therapy in valvular atrial fibrillation: joint position document from EHRA and WG thrombosis
  • Speaker : J A C Morais (Leiria,PT)

Tailored antiplatelet therapy in PCI - Take home message on the cases presented

Congress : ESC Congress 2017

  • Session : Tailored antiplatelet therapy in PCI
  • Speaker : J A C Morais (Leiria,PT)

Anticoagulation for secondary prevention.

Congress : Acute Cardiovascular Care 2016

  • Session : Secondary prevention after acute coronary syndromes
  • Speaker : J A C Morais (Leiria,PT)
  • Joint session with the European Association of Preventive Cardiology (EAPC)

Introduction.

Congress : Acute Cardiovascular Care 2016

  • Session : Rationale for addressing symptoms and organ injury in acute heart failure treatment
  • Speaker : J A C Morais (Leiria,PT)
  • Sponsored by Novartis

Optimal duration of dual antiplatelet therapy study after ACS.

Congress : Acute Cardiovascular Care 2016

  • Session : Dilemmas in anti thrombotic therapy
  • Speaker : J A C Morais (Leiria,PT)
  • Joint session with the ESC Working Group on Thrombosis - This session is supported by an unrestricted educational grant from AstraZeneca

Role of intravenous agents

Congress : ESC Congress 2016

  • Session : Bridging of antithrombotic therapy for invasive procedure
  • Speaker : J A C Morais (Leiria,PT)

Welcome to Lisbon on behalf of the Portuguese Society of Cardiology

Congress : Acute Cardiovascular Care 2016

  • Session : Inaugural session
  • Speaker : J A C Morais (Leiria,PT)

Dual antiplatelet therapy beyond one year after stenting

Congress : EuroPrevent 2015

  • Session : Antithrombotic therapy in stable patients
  • Speaker : J A C Morais (Leiria,PT)

How to prevent bleeding in acute coronary syndrome?

Congress : ESC Congress 2015

  • Session : Patients with acute coronary syndromes: bleeding and blood transfusion
  • Speaker : J A C Morais (Leiria,PT)

Invitation to Acute Cardiovascular Care 2016.

Congress : Acute Cardiovascular Care 2015

  • Session : Highlights from Acute Cardiovascular Care 2015 & Closing Ceremony
  • Speaker : D Zahger (Beer Sheva,IL), J A C Morais (Leiria,PT)

Panel discussion & Q&A - Prevention of atherothrombotic events: what's the new evidence?

Congress : ESC Congress 2015

  • Session : Prevention of atherothrombotic events: what's the new evidence?
  • Speaker : P G Steg (Paris,FR), D A Morrow (Boston,US), J A C Morais (Leiria,PT), G M De Ferrari (Pavia,IT)
  • Sponsored by MSD

Protease Activated Receptor-1 (PAR-1) antagonist: emerging evidence for a novel pathway.

Congress : ESC Congress 2015

  • Session : Prevention of atherothrombotic events: what's the new evidence?
  • Speaker : J A C Morais (Leiria,PT)
  • Sponsored by MSD

Risk and prognostic impact of bleeding.

Congress : Acute Cardiovascular Care 2015

  • Session : Risk and management of bleeding in ACS
  • Speaker : J A C Morais (Leiria,PT)

State of the Art in use of antithrombotics in acute coronary syndromes.

Congress : ESC Congress 2015

  • Session : Antithrombotic drugs - An ongoing research
  • Speaker : J A C Morais (Leiria,PT)

Atrial fibrillation.

Congress : ESC Congress 2013

  • Session : Antithrombotics in heart failure
  • Speaker : J A C Morais (Leiria,PT)

What are the main unmet needs after a myocardial infarction (MI)?

Congress : ESC Congress 2013

  • Session : The future of anti-thrombotic therapy: reducing long term risk in patients with myocardial infarction
  • Speaker : J A C Morais (Leiria,PT)
  • Sponsored by MSD

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are